Jailing of transvenous leads during transcutaneous tricuspid valve replacement: A perilous future?

HeartRhythm Case Reports 2026 Open access

Read full text
Authors: Jeffrey Kolominsky, Frank Matthias Bogun, Mohammed Saeed, Amrish Deshmukh
DOI: 10.1016/j.hrcr.2026.03.005
Cited by: 0
References: 9

Abstract

Transcutaneous tricuspid valve replacement (TTVR) is one of the expanding procedures in the field of structural interventional cardiology to treat severe tricuspid regurgitation (TR) and frequently employed when edge-to-edge repair is not deemed feasible.1 Roughly one-third of patients referred for TTVR have pre-existing cardiac implantable electrical devices (CIEDs) which may or may not be causally linked to TR itself, the management of which includes transvenous lead extraction ahead of TTVR or jailing of the current leads.

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Cardiac pacing and defibrillation studies Cardiac Arrhythmias and Treatments

Publication details

Journal / source
HeartRhythm Case Reports
Volume
12
Issue
6
Pages
599–602
Publication date
12 March 2026
Language
EN